PHARMACYTE BIOTECH, INC. Investments and Other Noncurrent Assets
PHARMACYTE BIOTECH, INC. (PMCB) had Investments and Other Noncurrent Assets of $22.47 million as of 2026-01-31, per its 10-Q filed 2026-03-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InvestmentsAndOtherNoncurrentAssets · last filed 2026-03-17
- 2026-01-31: Investments and Other Noncurrent Assets $22.47M.
- 2025-10-31: Investments and Other Noncurrent Assets $20.75M.
- 2025-07-31: Investments and Other Noncurrent Assets $19.64M.
- 2025-04-30: Investments and Other Noncurrent Assets $22.47M.
| Period end | Investments and Other Noncurrent Assets |
|---|---|
| 2026-01-31 | $22.47M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $20.75M 10-Q · filed 2025-12-18 |
| 2025-07-31 | $19.64M 10-Q · filed 2025-09-15 |
| 2025-04-30 | $22.47M 10-Q · filed 2026-03-17 |
| 2025-01-31 | $18.63M 10-Q · filed 2025-03-17 |
| 2024-10-31 | $24.86M 10-Q · filed 2024-12-13 |
| 2024-07-31 | $29.12M 10-Q · filed 2024-09-17 |
| 2024-04-30 | $0.00 10-K · filed 2025-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |